Pomerantz Law Firm Alerts Marqeta Shareholders on Class Action Lawsuit and Key Deadlines

On December 20, 2024, Pomerantz LLP announced a class action lawsuit against Marqeta, Inc., commonly referred to as Marqeta, which is listed on the NASDAQ under the ticker symbol MQ. This lawsuit draws the attention of investors, especially those who have suffered financial losses from their investments in the company. It is important for shareholders who are impacted to note the upcoming deadlines and to seek guidance on how they can assert their rights.

The lawsuit arises from allegations that Marqeta, along with certain executives and board members, may have engaged in securities fraud or potentially unlawful business practices. Investors who purchased Marqeta’s securities during the designated class period have until February 7, 2025, to request the court to appoint them as lead plaintiffs in this matter. For more information regarding the legal proceedings, shareholders are encouraged to reach out to attorney Danielle Peyton at Pomerantz LLP, either through email or via phone, and should include relevant personal information such as their contact details and the number of Marqeta shares they acquired.

The preliminary trigger for the lawsuit was a press release from Marqeta on November 4, 2024, in which the company disclosed disappointing financial results for the third quarter of 2024. The reported data indicated weaker-than-anticipated performance and provided a guidance outlook for the fourth quarter that raised concerns among investors. CEO’s remarks during the related earnings call pointed to several influences, including evolving regulatory conditions affecting smaller banks, which are crucial for many of Marqeta’s customer programs.

Following the announcement of these unfavorable results and insights from company leadership, Marqeta's stock experienced a significant decline, plummeting by $2.53, or a staggering 42.52%, to close at $3.42 per share on November 5, 2024. This abrupt decrease in stock value highlighted the potential impact of the management’s disclosures on shareholder confidence and market perception.

Pomerantz LLP is recognized as a prominent firm specializing in class action litigation, particularly in the realms of corporate, securities, and antitrust cases. With a legacy spanning more than 85 years and founded by the notable Abraham L. Pomerantz, the firm has consistently advocated for the rights of investors adversely affected by illegal corporate actions. To bolster their stature, Pomerantz has successfully recovered billions of dollars in settlements for class members previously victimized by securities fraud and related corporate misconduct.

Given the serious nature of this lawsuit and the potential implications for shareholders, individuals affected by Marqeta’s recent stock fluctuations are strongly encouraged to engage with legal counsel to ensure their interests are adequately represented in this class action. For those interested in participating, the firm has made relevant details about joining the class action readily accessible for potential plaintiffs.

For shareholders of Marqeta, it is crucial to acknowledge not just the financial losses but also the legal recourse options available to reclaim losses through collective action. Pomerantz LLP remains a key player in this ongoing situation, and by partnering with them, shareholders can navigate the complexities of the legal landscape effectively. Remember, the timeline for asserting your rights is short, so act quickly to ensure your position is safeguarded in this class action lawsuit against Marqeta, Inc.

For future updates and additional resources, you can visit Pomerantz’s official website or directly contact their office for personal assistance regarding the class action process and your investment in Marqeta.

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.